Drug Recalls: Regulatory Process and Manufacturer Responsibilities
A drug recall is a regulatory action initiated when a medicinal product is found to deviate from established quality, safety, or labeling standards. Recalls may result from manufacturing defects, contamination, stability failures, mislabeling, or emerging safety data.
Regulatory authorities classify recalls based on the level of risk to public health. Higher-risk classifications require immediate communication and corrective measures, while lower-risk cases may involve precautionary withdrawal or labeling updates. Authorities oversee the recall process to ensure transparency, traceability, and effective risk mitigation.
Manufacturers are responsible for maintaining robust quality management systems, batch traceability, complaint handling procedures, and corrective and preventive actions (CAPA). Prompt internal investigation, notification to regulatory bodies, and structured communication with distributors and healthcare providers are essential components of compliance.
A well-managed recall system reflects the effectiveness of a company’s pharmacovigilance and quality assurance frameworks and supports the overarching objective of safeguarding patient safety.
